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Skeletal Muscle Induced, BDNF-Mediated Secretions Retrogradely Initiates Pro-Neuroplastic Signaling Cascade That Increases Cognitive Function in Adults with Autism Spectrum Disorder
Julie L. Dalmolen, Lukas Coppen,M.S., Maya DiMaio, David Adams Ph.D., Eli Lankford Ph.D., Brian Blackburn Ph.D.
Obesity, Diabetes and Metabolism Lab, Department of Kinesiology, Cal Poly Humboldt, Arcade, CA, USA

Introduction
Autism Spectrum Disorder (ASD) is a neuro-cognitive condition associated with
pathogenic neuroplasticity (1). This condition critically impacts communication as
well as social and cognitive behavior in individuals with ASD. Brain Derived
Neurotrophic Factor (BDNF) is a growth signaling protein implicated in augmenting
neuroplasticity by facilitating axon elongation, synaptic proliferation, and
neurotransmitter formation and release by binding to its key receptor Tropomyosin
Receptor Kinase B (Trkb) (2). Interestingly, human skeletal muscle (HSM) has been
identified as a BDNF secreting tissue capable of initiating pro-neuroplastic molecular
events that support central and peripheral neural remodeling (3). Research conducted
on rodents has demonstrated that chronic exercise significantly increases the
expression of both proBDNF(pBDNF) inactive isoform, mature BDNF(mBDNF)
active isoform, and cognitive function (4).Thus, HSM may represent a novel
mechanism capable of enhancing systemic neural remodeling. Investigations
conducted on other neurodegenerative disorders report that exercise favorably
influences total BDNF expression and concentration (5), thus promoting retrograded
muscle mediated central and peripheral neuro-remodeling. In this study, we intend to
use moderate intensity aerobic exercise (AE),  60% heart rate reserve and
maximum oxygen uptake (VO2max), as an intervention to induce BDNF secretion in
HSM. The researchers hypothesize that chronic exercise may be a critical catalyst in
inciting contraction-mediated, muscle-induced BDNF proliferation capable of
supporting neural remodeling across the peripheral (PNS) and central nervous
systems (CNS). Further, the researchers believe that these changes may be a key
factor in improving social and cognitive deficits associated with ASD.

Muscle-induced BDNF Proliferation Sequence

Methods
Participant description
This study will be conducted at a university in Northern California and will include Neurotypical
participants (NT;n=10) and participants with Moderate (mASD;n=10) and Severe (sASD;n=10)
ASD. All Participants will perform a 6-week AE intervention program.
Inclusion criteria require informed consent, participants to be inactive and 18 years of age or older,
and 3 months free from BDNF enhancing medication.
Cognitive Assessment
Once inclusion criteria is met, participants will undergo the Woodcock Johnson 4th version cognitive
assessment, both pre and post exercise intervention.
Bio fluid Collection/Bio Marker Detection
Three 24- hour consecutive urine samples will be collected during visits 3-5 and 6-8. Visit 5 and 8
will involve one 5mL blood draw after a 12 hour fast.
Bio marker detection
Commercially available ELISA kits will be used to determine the presence and concentration levels
of total BDNF (proBDNF & mBDNF) in bio fluids collected in the study. Urine samples will
undergo gas spectrometry analysis for identification of additional biomarkers. Blood BDNF analyses
will require a collection of venous blood collected from participants following an overnight fast.
Blood samples will be allowed to coagulate at room temperature for 30 min. Real Time PCR will
also be employed to determine BDNF gene expression.
Intervention
Baseline aerobic fitness will be determined by a treadmill test to establish VO2max, an index of the
maximum capacity to transport and utilize oxygen during incremental AE. A modified VO2max
algorithm will be used to predict the > 60% maximum heart rate and VO2max of the exercising
participants. Post assessments will assume participants to be exercising at an intensity > 60% of
either their maximum heart rate or VO2 max. Exercise sessions will be monitored by an exercise
physiologist and or personal trainer. Participants will have a choice of a treadmill, elliptical, row
machine, stationary bike, and active-play video games (Xbox 360 Kinect) and traditional AE
equipment.

Mechanism of Action

Proposed Results
In NT individuals, we anticipate that exercise will result in a decrease in proBDNF and an increase
in mBDNF, suggesting BDNF activation will induce normal physiological neuro-remodeling and
maintenance.
Previously reported investigations have indicated that individuals with mASD exhibit higher levels
of serum and urinary BDNF than their NT counterparts. Although concentrations of the BDNF
protein levels were elevated, there is a void in the literature concerning whether the BDNF levels
are active or inactive. In the mASD group, we anticipate exercise will increase proBDNF gene
expression, and protein levels and moderately increase mBDNF. These conjectures suggest that
exercise not only provokes gene expression but also enhances the catalytic activity of the enzyme
Intercellular Furin Convertase (IFC).
In the sASD group, both pBDNF and mBDNF will be blunted compared to mASD and NT groups.
We predict that exercise will produce a robust response in both the inactive and active forms of
BDNF. These results suggest that exercise increases gene expression, upregulates BDNF protein
levels, and augments IFC activity.

Discussion
The objective of this study is to identify exercise as an effective therapy for improving
cognitive function in individuals with ASD. Moderate intensity AE is one activity that is
known to up-regulate BDNF, with synthesis and release into the peripheral nervous
system that increases in a dose-response manner (3). Exercise as a therapy for
individuals with ASD is important as a sedentary lifestyle is associated with this
community (6) In addition to weight-management, cardiovascular and other physical
health benefits, AE could partially ameliorate neurocognitive deficits in individuals with
ASD and serve as a safe and side-effect free intervention. The researchers predict that the
results of this study will demonstrate that moderate intensity AE improves cognitive
function through an increase in BDNF through the collective cellular pathways of the
PNS and CNS which are genetically driven by the stimulus of chronic skeletal muscle
contraction elicited by AE.
For references and additional information such as study protocol and participant activities
within this investigation, contact Julie Dalmolen at jlb77@humboldt.edu

